RESUMO
Dirithromycin is a 9-N-11-O-oxazine derivative which is formed by condensation of 9(S)-erythromycylamine with 2-(2-methoxyethoxy)acetaldehyde. Dirithromycin is hydrolyzed, either under acidic conditions or in vivo, to its major active metabolite, 9(S)-erythromycylamine. The antimicrobial spectrum of dirithromycin is similar to that of erythromycin; both antibiotics are active against gram-positive bacteria, Legionella spp., Helicobacter pylori, and Chlamydia trachomatis. Comparable results were obtained for each antibiotic in MIC and MBC determinations and in the potential development of resistance in vitro. The effects of human serum, bacterial growth media, test methodology, and inoculum size on MICs were similar for each antibiotic. In standard mouse protection studies, dirithromycin was more efficacious than erythromycin against experimental infections after subcutaneous administration of antibiotic. These results were consistent with pharmacokinetic studies in rodents, which showed that dirithromycin gave more persistent concentrations of antibiotic in serum and tissues than were achieved with erythromycin. These studies indicate that dirithromycin possesses antimicrobial activity comparable to that of erythromycin in vitro but is more active than erythromycin in vivo, which may be attributable to the persistence of antimicrobial activity in the tissue(s) of the test animals.
Assuntos
Antibacterianos/síntese química , Bactérias/efeitos dos fármacos , Eritromicina/análogos & derivados , Animais , Antibacterianos/farmacologia , Bactérias Anaeróbias/efeitos dos fármacos , Infecções Bacterianas/microbiologia , Infecções Bacterianas/prevenção & controle , Meios de Cultura , Avaliação Pré-Clínica de Medicamentos , Resistência Microbiana a Medicamentos , Endocardite Bacteriana/tratamento farmacológico , Eritromicina/síntese química , Eritromicina/farmacologia , Humanos , Macrolídeos , Camundongos , Testes de Sensibilidade Microbiana , Ratos , Ratos EndogâmicosRESUMO
The preparation and biological evaluation of a series of 7 beta-[2-(2-aminothiazol-4-yl)-2(Z)-methoximinoacetamido]cep halosporins, substituted at the 3'-position with monocyclic or bicyclic nitrogen-containing heterocycles are described. The resulting family of parenteral compounds displays a broad spectrum of antibacterial activity. Some compounds exhibit a similar level of Gram-negative activity to that of the "third-generation" cephalosporins with increased staphylococcal activity. The in vitro and in vivo antimicrobial activity, structure-activity relationships, beta-lactamase stability, and in vitro and in vivo pharmacological evaluations are presented.
Assuntos
Cefalosporinas/farmacologia , Animais , Pressão Sanguínea/efeitos dos fármacos , Cefalosporinas/metabolismo , Cefalosporinas/farmacocinética , Fenômenos Químicos , Química , Cães , Enterobacter/efeitos dos fármacos , Escherichia coli/efeitos dos fármacos , Feminino , Cobaias , Meia-Vida , Frequência Cardíaca/efeitos dos fármacos , Klebsiella pneumoniae/efeitos dos fármacos , Macaca mulatta , Masculino , Camundongos , Estrutura Molecular , Parassimpatolíticos/farmacologia , Pseudomonas aeruginosa/efeitos dos fármacos , Ratos , Serratia marcescens/efeitos dos fármacos , Staphylococcus aureus/efeitos dos fármacos , Streptococcus/efeitos dos fármacos , Relação Estrutura-Atividade , beta-Lactamases/metabolismoRESUMO
A54145 complex is made up of eight factors; A, A1, B, B1, C, D, E, and F which were active in vitro (MIC 0.25 approximately greater than 32 micrograms/ml) against Gram-positive aerobic organisms. The complex, factor B and B1 were found to be active against two strains of Clostridium perfringens. A calcium dependence study on some of the factors showed that their in vitro antibacterial activity was greatly enhanced by the presence of calcium (50 mg/liter) in the media. Resistance build-up was seen when Staphylococcus sp. and Streptococcus sp. were passed seven times in the presence of sublethal concentrations of A54145 antibiotics. This resistance disappeared immediately when the resistant organisms were passed in the absence of the antibiotics. Factor A was very effective against Staphylococcus aureus and Streptococcus pyogenes infections in mice (sc ED50s of 3.3 approximately 2.4 mg/kg x 2, respectively). Factor B was more active against S. pyogenes in vivo (sc ED50, 0.9 mg/kg x 2). Acute mouse toxicities were determined with these antibiotics. Semisynthetic derivatives were evaluated.
Assuntos
Antibacterianos/farmacologia , Infecções Estafilocócicas/tratamento farmacológico , Staphylococcus/efeitos dos fármacos , Infecções Estreptocócicas/tratamento farmacológico , Streptococcus/efeitos dos fármacos , Sequência de Aminoácidos , Animais , Antibacterianos/uso terapêutico , Antibacterianos/toxicidade , Cálcio/metabolismo , Clostridium perfringens/efeitos dos fármacos , Meios de Cultura , Resistência Microbiana a Medicamentos , Lipoproteínas/farmacologia , Lipoproteínas/uso terapêutico , Lipoproteínas/toxicidade , Camundongos , Camundongos Endogâmicos ICR , Dados de Sequência Molecular , Estrutura MolecularRESUMO
A novel low-molecular weight inhibitor of an aminoglycoside-inactivating enzyme, initially isolated from fermentation broths of Streptomyces neyagawaensis, was determined to be 7-hydroxytropolone. Its structure was confirmed by synthesis. In vitro synergy was demonstrated between 7-hydroxytropolone and certain aminoglycosides against bacteria which were resistant to those aminoglycosides by virtue of a 2"-O-adenylyltransferase. The synthesis and characterization of some analogs of 7-hydroxytropolone is also described.
Assuntos
Antibacterianos/biossíntese , Cicloeptanos/biossíntese , Nucleotidiltransferases/antagonistas & inibidores , Streptomyces/metabolismo , Tropolona/biossíntese , Antibacterianos/farmacologia , Bactérias/efeitos dos fármacos , Fenômenos Químicos , Físico-Química , Sinergismo Farmacológico , Fermentação , Tropolona/análogos & derivados , Tropolona/farmacologiaRESUMO
The antimicrobial activity of cinoxacin, 1-ethyl-4(1H)-oxo-[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid, previously reported as compound 64716, was determined and compared with other antimicrobial agents at a dosage of 12 mg/kg once daily in a descending pyelonephritis rat model with Escherichia coli and Proteus mirabilis as infecting organisms. Cinoxacin was considerably more effective than either nalidixic acid or oxolinic acid when all three were administered orally at 3 mg/kg four times daily. The presence of demonstrable serum activity with a high recovery in urine indicates cinoxacin possesses highly desirable properties of an effective oral chemotherapeutic agent for urinary tract infections.